Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BLUE JET HEALTHCARE LTD.

NSE : BLUEJETBSE : 544009ISIN CODE : INE0KBH01020Industry : Pharmaceuticals & DrugsHouse : Private

BSE1012.0040.9 (+4.21 %)

PREV CLOSE ( ) 971.10

OPEN PRICE ( ) 971.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 93642

TODAY'S LOW / HIGH ( )956.00 1021.50

52 WK LOW / HIGH ( )401.45 1021.5

NSE1010.2039.5 (+4.07 %)

PREV CLOSE( ) 970.70

OPEN PRICE ( ) 981.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1010.20 (1082)

VOLUME 923505

TODAY'S LOW / HIGH( ) 961.15 1015.00

52 WK LOW / HIGH ( )401.05 1015

Select year

Particulars

Mar 2021

Mar 2020

Operational & Financial Ratios

Earnings Per Share (Rs)

1396.44

24141.17

CEPS(Rs)

8.96

0.00

DPS(Rs)

0.00

Book NAV/Share(Rs)

3428.35

32017.33

Tax Rate(%)

26.47

25.33

Margin Ratios

Core EBITDA Margin(%)

41.30

39.71

EBIT Margin(%)

38.07

37.44

Pre Tax Margin(%)

37.01

36.07

PAT Margin (%)

27.22

26.93

Cash Profit Margin (%)

31.16

30.29

Performance Ratios

ROA(%)

26.50

33.58

ROE(%)

51.06

75.46

ROCE(%)

56.68

72.23

Asset Turnover(x)

0.97

1.25

Sales/Fixed Asset(x)

3.31

4.30

Working Capital/Sales(x)

2.20

4.66

Efficiency Ratios

Fixed Capital/Sales(x)

0.30

0.23

Receivable days

96.02

80.36

Inventory Days

68.30

46.80

Payable days

120.13

90.23

Valuation Parameters

PER(x)

0.00

PCE(x)

0.00

Price/Book(x)

0.00

Yield(%)

EV/Net Sales(x)

-0.02

0.12

EV/Core EBITDA(x)

-0.04

0.29

EV/EBIT(x)

-0.05

0.31

EV/CE(x)

-0.02

0.23

M Cap / Sales

0.00

Growth Ratio

Net Sales Growth(%)

-7.30

0.00

Core EBITDA Growth(%)

-2.10

0.00

EBIT Growth(%)

-5.72

0.00

PAT Growth(%)

-6.33

0.00

EPS Growth(%)

-94.22

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.15

0.40

Current Ratio(x)

2.03

1.60

Quick Ratio(x)

1.50

1.24

Interest Cover(x)

35.79

27.34

Total Debt/Mcap(x)